FUJIFILM Corporation

FUJIFILM Corporation has been developing proprietary ionizable lipids for LNP formulations. The most advanced one is FL-0445 used in Phase 3 studies of COVID vaccines. We recently developed a safer liver-targeting lipid with a comparable safety profile to one in clinical use by i.v. injection. And we have some candidates for liver de-targeting and also ex-vivo LNPs for KO/KI. CDMO service from mRNA to LNP manufacturing is also available.